entertainment -WSS

entertainment

author：comprehensive 2025-10-02 04:41:34 Page View：1

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Listen: PBM conflicts, RSV vaccines, & the future of flu season
Next article： Duchenne breakthrough therapy leaves behind pioneering families

comprehensive

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Ahumanpapillomavirus(HPV)infectionofthecevrix.WellcomeYou’dthinkiftherewereavaccinethatwouldpreventt

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Medical students need to learn the potent medicine of empathy

JoeRaedle/GettyImagesAfewyearsagoatalargeteachinghospitalinTexas,amedicalresidentaskedanursehowtoord

entertainment

knowledge

comprehensive

Medical students need to learn the potent medicine of empathy